To further examine whether miR-1275 inhibited chemoresistance in BC cells by inhibiting PI3K/Akt signaling axis, miR-1275 knock-out cells were treated with MDK inhibitor iMDK (MedChemExpress) or PI3K/Akt inhibitor LY294002 (Beyotime). This evidence concerns the gene AKT1 and breast cancer.